Eurosurv. Very low risk of monkeypox among staff and students after exposure to a confirmed case in educational settings, England, May to July 2022

[tetano]

• Shamez N Ladhani[SUP]1,2[/SUP] , Felicity Aiano[SUP]1[/SUP] , David S Edwards[SUP]3[/SUP] , Samantha Perkins[SUP]4[/SUP] , Wazirzada M Khan[SUP]4[/SUP] , Nalini Iyanger[SUP]5[/SUP] , Elizabeth Whittaker[SUP]6[/SUP] , Jonathan M Cohen[SUP]7[/SUP] , David Ho[SUP]7[/SUP] , Susan Hopkins[SUP]8[/SUP] , Mary E Ramsay[SUP]1[/SUP] , J Yimmy Chow[SUP]5[/SUP]

We investigated a secondary school (11–16 year-olds), a primary school (5–11 year-olds), reception year (4–5 year-olds) and a nursery (2–5 year-olds) following confirmed monkeypox in an adult in each educational setting during June and July 2022. MVA-BN vaccine was offered up to 14 days post exposure to 186 children < 12 years and 21 were vaccinated. No secondary cases occurred among at least 340 exposed students and more than 100 exposed staff during the 28-day follow-up period.


https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2022.27.40.2200734#html_fulltext